Can CA 19-9 predict inferior surgical and pathological outcomes for resectable pancreatic cancer?

被引：0
|
作者：
Jabbal, Iktej Singh
Nagarajan, Arun
Roy, Mayank
Rivera, Carlos
Yaghi, Marita
Liang, Hong
Nguyen, Timmy Q.
George, Tiffany L.
Nahleh, Zeina A.
Simpfendorfer, Conrad H.
机构：
[1] Cleveland Clin Florida, Weston, FL USA
[2] Cleveland Clin, Weston, FL USA
[3] Cleveland Clin Florida, Coral Springs, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16228
引用
收藏
页码：E16288 / E16288
页数：1
相关论文
共 50 条
  • [21] Preoperative CA 19-9 Kinetics as a Prognostic Variable in Radiographically Resectable Pancreatic Adenocarcinoma
    Brown, E.
    Canter, R.
    Bold, R.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S99 - S100
  • [22] Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9
    Kowalchuk, Roman O.
    Lester, Scott C.
    Graham, Rondell P.
    Harmsen, William S.
    Zhang, Lizhi
    Halfdanarson, Thorvardur R.
    Smoot, Rory L.
    Gits, Hunter C.
    Ma, Wen Wee
    Owen, Dawn
    Mahipal, Amit
    Miller, Robert C.
    Wittich, Michelle A. Neben
    Cleary, Sean P.
    McWilliams, Robert R.
    Haddock, Michael G.
    Hallemeier, Christopher L.
    Truty, Mark J.
    Merrell, Kenneth W.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [23] Preoperative CA 19-9 Kinetics as a Prognostic Variable in Radiographically Resectable Pancreatic Adenocarcinoma
    Brown, Erin G.
    Canter, Robert J.
    Bold, Richard J.
    JOURNAL OF SURGICAL ONCOLOGY, 2015, 111 (03) : 293 - 298
  • [24] THE SEROLOGIC MARKER CA 19-9 AND PANCREATIC-CANCER
    NARDONE, DA
    ANNALS OF INTERNAL MEDICINE, 1989, 111 (02) : 184 - 185
  • [25] CA 19-9 serum course and prognosis of pancreatic cancer
    Safi, F
    Schlosser, W
    Falkenreck, S
    Beger, HG
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 1996, 20 (03) : 155 - 161
  • [26] CA 19-9 in pancreatic cancer - from diagnosis to therapy
    Rainer, Klapdor
    TUMOR BIOLOGY, 2006, 27 : 19 - 19
  • [27] CA 19-9 and Lewis Antigens in Pancreatic Cancer Reply
    Berger, Adam C.
    Hoffman, John P.
    Winter, Kathryn
    Regine, William
    Safran, Howard
    Abrams, Ross
    Willet, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15) : 2573 - 2573
  • [28] Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens
    Haab, Brian B.
    Huang, Ying
    Balasenthil, Seetharaman
    Partyka, Katie
    Tang, Huiyuan
    Anderson, Michelle
    Allen, Peter
    Sasson, Aaron
    Zeh, Herbert
    Kaul, Karen
    Kletter, Doron
    Ge, Shaokui
    Bern, Marshall
    Kwon, Richard
    Blasutig, Ivan
    Srivastava, Sudhir
    Frazier, Marsha L.
    Sen, Subrata
    Hollingsworth, Michael A.
    Rinaudo, Jo Ann
    Killary, Ann M.
    Brand, Randall E.
    PLOS ONE, 2015, 10 (10):
  • [29] CA 19-9 in pancreatic cancer: retrospective evaluation of patients with suspicion of pancreatic cancer
    Molina, Victor
    Visa, Laura
    Conill, Carles
    Navarro, Salvador
    Escudero, Jose M.
    Auge, Jose M.
    Filella, Xavier
    Lopez-Boado, Miguel A.
    Ferrer, Joana
    Fernandez-Cruz, Laureano
    Molina, Rafael
    TUMOR BIOLOGY, 2012, 33 (03) : 799 - 807
  • [30] CA 125 AND CA 19-9 AS TUMORAL MARKERS IN PANCREATIC-CANCER
    PASQUALI, C
    SPERTI, C
    DANDREA, AA
    PETRIN, P
    PEDRAZZOLI, S
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1986, 18 (04): : 235 - 235
12345